Tuesday, June 02, 2020 7:58:32 PM
Today we had the Pfizer fund for new biotechs that appears to be tailor-made for BOTH Brilacidin and Kevetrin. Any new source of funding, whether we use it or not, helps IPIX not have to accept a low-ball offer and puts Leo/LW in a much stronger negotiating position.
Then we hear about the newly introduced DISARM Act which allows Medicare to pay hospitals to use new antibiotics to help fight superbugs and this should rapidly expand the possibilities for getting ABSSSI into commercial status much quicker than most thought possible.
I may be quite biased but both the Pfizer and the DISARM projects seem to have been written almost exclusively for Brilacidin.
I thought we would get lung tissue results early this week, but the news that keeps coming out shows that Brilacidin should be a "hot potato" in the world of BPs right now as all its indications are coming to the forefront.
Leo must be doing so much dancing that he is probably losing a lot of weight. Can't blame him. I know I have a nice spring in my step as of late.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM